Open Nav
2016 Speakers

2017 speakers have not yet been announced. Check back for updates.

Marcelo do Amaral, PhD, Chief Executive Officer, GlobalYeast 

As the Chief Executive Officer of GlobalYeast Marcelo is responsible for the implementation of the company business plan, the coordination of the Business Development and Research & Development, and also the Administration and Finance activities.

Chemical engineer and European Doctor cum magna laude from the University of the Basque Country, he has experience in the sugar-ethanol and chemical industry, academia, and management consulting. A plenary speaker and chairman in the Gordon Research Conference, Marcelo has published in several peer review magazines, is the inventor of 5 patents, acts as reviewer, and combines scientific and technological knowledge with business acumen.

Prior to joining GlobalYeast, Marcelo held positions in reference companies from the Sugar&Ethanol industry, Management Consulting, Chemical Industry and Academia.

John Biggs, Research & Development, Director Latin America, Dow

John joined Dow in 1984.  He is currently a member of the Dow Latin America Leadership Team (LALT).

During his career in Dow, he has worked in number of roles in Building & Construction, Specialty Plastics then Polyethylene in various locations in Europe.  He was responsible for the launch of a number of new products in the Plastics area in this time.  These were products based on Dow INSITE* Technology, AFFINITY, ENGAGE & ELITE.

He moved to Argentina in 2001 to support the growth and development of the Plastics business for Dow in Latin America as Director for Polyethylene Technical Service & Development (TS&D).   He later expanded his role for all Plastics and then moved to São Paulo in 2005 to cover the R&D organization for all products within Dow apart from AgroSciences.

John has recently moved his focus within the organization to work on Alternative Feedstock developments focusing on Renewable Chemistry solutions for our businesses.

As a member of the Dow Latin America Leadership Team, he is responsible for driving Innovation initiatives for Dow in the area, including external networks with Universities, Start-ups and new technology developments.

John holds a BSc in Chemistry & Polymer Science from South Bank Polytechnic, London, UK.

Bob Blouin, Dean, University of North Carolina, Eshelman School of Pharmacy

Robert A. “Bob” Blouin is the Dean and Vaughn and Nancy Bryson Distinguished Professor of the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill. Dean Blouin also serves as the Director of the Eshelman Institute for Innovation that was created following a $100M gift from Dr. Fred Eshelman to pursue high-risk, high-reward ideas that advance innovation in education, research, and healthcare. Prior to his July 1, 2003 appointment as Dean, he was a long-time faculty member and administrator with the University of Kentucky College of Pharmacy. During that period, Dean Blouin served as the Associate Dean for Research and Graduate Education (1997-2003) and Executive Director of the Office for Economic Development and Innovations Management (2000-2003). During his thirteen-year tenure at UNC, the UNC Eshelman School of Pharmacy has experienced unprecedented growth in its research, education, and global engagement programs. The School is recognized as one of the premier pharmacy programs in the world as evidenced by its rankings with U.S. News & World Reports, QS World University Rankings in Pharmacy and Pharmacology, and AACP Grants and Contracts. In addition, the School successfully launched a unique and innovative professional degree granting partnership program in Asheville, NC, which focuses on ambulatory care and rural health. The School has been involved in the development of several new school-based research centers (Center for Integrative Chemical Biology and Drug Discovery; Center for Pharmacogenomics and Individualized Therapy; Center for Medication Optimization through Practice and Policy; Center for Innovation in Pharmacy Simulation; and Center for Nanotechnology in Drug Delivery). To support this growth, the School has been successful in significantly expanding its footprint on the UNC campus through the construction of two new research buildings, Genetic Medicine Building and Marsico Hall, in collaboration with the UNC School of Medicine. Dean Blouin led an effort to reengineer the School’s business operations. This includes the creation of an integration business management software program called InfoPorteTM, which has been adopted by the entire university as the interface dashboard for all business systems. Dean Blouin has received many awards and recognitions including the Ohio State Milap Nahata Distinguished Lecturer Award, the University of Kentucky College of Pharmacy Hall of Distinguished Alumni Award, and the University of North Carolina General Alumni Association Faculty Service Award. He has been selected as a Fellow of both the American College of Clinical Pharmacy (ACCP) and the American Association of Pharmaceutical Scientists (AAPS). Dean Blouin has led a national discussion on the issues of clinical pharmaceutical scientist training, particularly at the graduate level. He has been extensively involved in launching a transformation in the professional and graduate curricula at UNC coined the Educational Renaissance. Dean Blouin’s research interests include studying the effect of disease and altered physiologic status on the pharmacokinetics and pharmacodynamics of drugs.

Sekhar Boddupalli, PhD, President, Intrexon Crop Protection

Sekhar Boddupalli, PhD, is President of Intrexon Crop Protection and leads Ag Biotech Division at Intrexon Corporation. Prior to Intrexon he served as Global Consumer R&D lead for Monsanto Vegetable Seeds Division for nine years. In that capacity, he was responsible for understanding flavor, color, aroma and nutrient attributes of vegetables and translating them to products such as Beneforte® broccoli, Melorange® melon and Evermild® onion. Dr. Boddupalli has 20+ years of experience in agriculture, food, and consumer areas. He holds several patents and publications. He held research faculty appointments in biochemistry at the UT Southwestern Medical Center in Dallas, Texas and holds a PhD in biochemistry from the Indian Institute of Science in Bangalore.

Paulo Braga, Group Vice President, Clinical & Medical Affairs for Latin America, Genzyme/Sanofi

Paulo Braga, MD., is Medical Head for Sanofi Genzyme for Latin America. In this role, he is responsible for the oversight of medical affairs activities related to Sanofi Genzyme therapeutic areas for the region. He joined Genzyme in 2005 as Vice President for Clinical & Medical Affairs for Latin America where he was responsible for the implementation of the first clinical trials and the organization of medical affairs and pharmacovigilance structure throughout Latin America countries. Prior to joining Genzyme, he worked for several pharmaceutical companies, including Glaxo Welcome and GlaxoSmithKline, Brazil, where he was Medical Director. He previously worked at Sanofi Winthrop, where he was responsible for the implementation of clinical research activities in the Brazil subsidiary. Earlier in his career, he was a senior clinical research physician at Merck AG in Brazil. Paulo earned a degree in medicine from Federal Fluminense University in Rio de Janeiro. He earned a post-graduate degree in allergy and clinical immunology and M.B.A. in healthcare management from Rio de Janeiro Federal University.

Bruno Brasil, PhD, Researcher, The Embrapa Agro-Energia Biochemical Process Lab

Dr. Bruno Brasil received a degree in Biological Sciences (2004), a Masters in Microbiology (2006), and a PhD in Microbiology (2010) from the Federal University of Minas Gerais (UFMG). From 2010 to 2012 Dr. Brasil developed postdoctoral activity in molecular genetics at the same institution. Since 2012, Dr. Brasil has been a researcher at the Brazilian Agricultural Research Corporation (EMBRAPA), working in the area of microalgae genetic resources for the production of biofuels and bioproducts. In 2016, Dr. Brasil became coordinator of the EMBRAPII Unit: Renewables Biochemistry, headquartered in EMBRAPA Agroenergy. Dr. Brasil is the author and inventor of 3 technologic products already transferred to the private sector and currently marketed. In addition, Dr. Brasil has produced to date 3 patent applications, 23 scientific papers published in indexed journals (H Index = 7), and two book chapters. Dr. Brasil is co-founder of the technology-based company Myleus Biotechnology. In 2014, the company received investment fund FUNDEPAR investments, becoming Myleus Analysis Genetic SA. Dr. Brasil is also a professor at the post-graduation programs in Biotechnology of Federal do Tocantins Universities (Brazil) and Bahia (Brazil) and at the post-graduation program in Chemical and Biological Technologies at the University of Brasilia (UNB).

Carlos Eduardo Cavalcanti, Head of Biofuels Department, The Brazilian Development Bank (BNDES)

Carlos Eduardo Cavalcanti holds a degree in engineering from the Catholic University of Rio de Janeiro (PUC-RJ), and MBA degrees in Finance from PUC-RJ and in International Business Development from Fundação Dom Cabral - Belo Horizonte/MG. He joined BNDES in 1992, assuming executive position in 1996 at the Export Credit Division. Since 2007 he has worked at the BNDES Industrial Division, in charge of the Biofuels Department, a Bank’s unit mainly dedicated to bioethanol and biopower generation projects, as well as to the introduction of new technologies in the sugarcane industry.

Bernard Chaud, Vice President of Industrial Strategy, Global Bioenergies

Bernard Chaud is 55 and graduated from Ecole Polytechnique and Ecole Nationale du Génie rural des eaux et des forêts. He has extensive experience in process industry related to agriculture and is interested in promoting new activities and new business based on new technologies. As early as the beginning of his career - in the mid 80’s just after the oil crisis of the 70’s- , Bernard got involved in biofuels with “Institut français du Pétrole”, known as IFP. But with depressed oil prices, interest for biofuels vanished at the end of the 80’s and only resumed in the beginning of the present century. Bernard has again been involved in biofuels since 2003. Bernard joined Global Bioenergies in 2015 as Vice President for Industrial Strategy and is the CEO of IBN-One. IBN-One is a joint venture between Global Bioenergies and Cristal Union (N°2 beet sugar producer in France). IBN-One’s project is to build and operate the first commercial plant producing bio-based isobutylene. Prior to joining Global Bioenergies, Bernard was at Tereos (the biggest French sugar beet producer) and was in charge of developing policy in the field of biofuels since 2007. Previously he was head of the unit for biomass and biofuel in the french department for agriculture. From 2003 to 2005 he participated to the revision of the European sugar “Common Market Organisation” on the behalf of France and took active part to the french “plan biocarburant” in 2006. During the 90’s Bernard worked for the French potash industry. During this period he had the opportunity to deal with chemical and fertilizer production and business.

Paulo Coutinho, PhD, Director, SENAI Innovation Institute in Biosynthetic

Dr. Paulo Luiz De Andrade Coutinho has a BSc in Chemical Engineering, a MSc in Chemical Processes and a Dr degree in Innovation Management (UFRJ). From 1983 until 2008 he worked as a Process Engineer, Researcher and Technical Manager at Petroflex, being author of a number of patents. In 2008, he became Open Innovation Manager at Braskem. Since 2010, he conceived, developed and implemented Braskem’s roadmap on chemicals, monitoring, identifying and evaluating opportunities in renewable chemicals. In 2014, he became responsible for Knowledge Management and Intellectual Property area. In 2016, he took over the implementation of SENAI´s Biosynthetic Innovation Institute in Rio de Janeiro.

Carlos Henrique de Brito Cruz, PhD, FRSC, Scientific Director, São Paulo Research Foundation (FAPESP)

Professor Carlos Henrique de Brito Cruz is the Science Director for the São Paulo Research Foundation (FAPESP). A researcher in the field of Physics of Ultrafast Phenomena, he has been a visiting researcher at the Quantum Optics Laboratory at the Universitá di Roma, at the Femtosecond Research Laboratory at the Universitè Pierre et Marie Curie, and a resident researcher at the AT&T's Bell Laboratories. Prof. Brito Cruz studied at the Aeronautics Technology Institute (ITA) and at Unicamp, in Brazil. He is a member of the Brazilian Academy of Sciences, a Fellow of the AAAS, received the Ordre des Palmes Academiques de France, the Order of the Scientific Merit from the Federative Republic of Brazil, and the Order of the British Empire, Honorary (OBE).

Eduardo Emrich, President and Chief Executive Officer, Biominas Brasil

President & CEO since 2003. Has over 25 years of experience in identifying and analyzing opportunities as well as in structuring and managing businesses and projects aimed at promoting the Life Sciences sector.

Pedro Luis Fernandes, Vice President of Corporate Affairs & Sustainability for Latin America, Novozymes

Since 2015, Pedro Luiz Fernandes occupies the position of Vice President of Corporate Affairs & Sustainability, Latin America at Novozymes. Mr. Fernandes joined Novozymes in 1988 and was Regional President for 7 years before becoming the Vice President of Corporate Affairs & Sustainability, Latin America. He is director of the Danish-Brazilian Chamber of Commerce (Danchamb) in São Paulo and a regional Danchamb’s representative in Paraná State. In 2012, Mr. Fernandes was honored by the Danish Government with the title of “Honorary Consul of the Kingdom of Denmark” for the States of Paraná and Santa Catarina in Brazil. He is Vice president and co-founder of the Princess Benedikte Institute, an institution that operates in the area of childhood and adolescence safeguarding the rights of children and youths victims of domestic violence or at risk. He is also a representative of Novozymes Latin America Ltda. at Global Compact Brazilian Network and member of two Working Groups: Climate & Energy and Food & Agriculture. Mr. Fernandes holds a BS in Chemistry by the Pontifical Catholic University of Paraná (PUC/PR). He currently participates as Master's Degree candidate in Governance & Sustainability at ISAE / FGV - Institute of Business and Economics in Curitiba – Paraná.

Maria Sueli Soares Felipe, PhD, Professor, Catholic University of Brasília

Maria Sueli Soares Felipe received an undergraduate degree in chemistry (1975) and Masters in Biological Sciences and Molecular Biology (1978) from the Federal University of Brasilia (UNB), and a Ph.D. in Biochemistry from São Paulo University (USP) and University of Manchester Institute of Science and Technology (UMIST- UK). Dr. Felipe is the former director of Development Programs and Policy’s Department at the Brazilian Ministry of Science Technology and Innovation (MCTI). She is currently a Senior Researcher at UNB, where she was a Professor from 1980 to 2010. Dr. Felipe coordinated the genome project network of the Brazilian Midwest area and is a member of the National Network of the Brazilian Genome. She was the former Director of the post-graduation program and is currently a Professor at the Universidade Católica de Brasília (Catholic University of Brasilia - PUC). Dr. Felipe is a member of the Innovation and Technology Consultant Center (Nati) from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq - National Counsel of Technological and Scientific Development) and worked as the Innovation Coordinator the Agência Brasileira de Desenvolvimento Industrial (ABDI - Brazilian Agency for Industrial Development) on projects with biotechnology and nanotechnology industries.

Jaime Finguerut, Industrial Strategic Development, Centro De Technologia Canavieira (CTC), (Brazil)

Jaime Finguerut, chemical engineer, is a Technical Advisor for CTC. He has more than 35 years of experience in the development of biotechnology processes applied to the biofuels industry in Brazil. He led the big increases in yield and productivity of the industrial, large scale, non-asseptic ethanol fermentation process where Brazil is a global leader. He joined CTC ñ Centro de Tecnologia Canavieira in 1980.

Previously, Jaime worked as teacher and researcher for FEI ñ Faculdade de Engenharia Industrial at S„o Bernardo do Campo, making part of a network of biotechnology researchers at University of S„o Pauloí Escola PolitÈcnica and IPT ñ Instituto de Pesquisas TecnolÛgicas as well as at Escola de Engenharia Mau·, developing several aspects of yeast fermentation and physiology. He also worked at CETESB, the state of S„o Pauloí Environment Protection agency developing the anaerobic biodigestion process to convert residues in biogas for energy.

Marcelo de Franco concluded the doctoral studies on Immunology at University of São Paulo in 1992. He made the post doctorate studies at Institute Curie, France in 1993, at University Paris 7 in 1994, University of Florida –USA in 1998 and at Institute dei Tumore de Milano in 2005. Now is scientific researcher (PqC-6) at Instituto Butantan, being deputy director. He works as advisor at University of São Paulo (immunology) and at the Instituto Butantan (toxicology). He published 43 full papers and 33 short papers in specialized journals, as well as 179 abstracts in annals of congress events. He advised seven dissertations and five doctoral theses. Four awards were received. The scientific research line is on Immunology area, with emphasis on Immunogenetics. The following grants were received: CNPq Universal 2010, process 471010/2010-3, R$ 83.500,00. FAPESP process 09/15822-0, R$ 174.500,00 and US$ 98.000,00. FAPESP process 06/00015-4, R$ 212.500,00 and US$ 18.000,00. CNPq Universal 2006 process 470244/2006-2, R$ 30.590,00. FAPESP process 03/05486-7, R$ 230.000,00 and US$ 190,000.00. FAPESP process 02/06496-3, R$ 119.000,00 and US$ 11,800.00. FAPESP process n. 98/07854-3, R$ 165.654,00. FAPESP process n. 95/09377-0, US$ 150,000.00 and R$ 45.000,00.

Ricardo Garcia, Director, CLAPBio

Education and Training:

  • Medical Doctor (1994).
  • General Surgery Residency Program (1997).
  • Post Graduated in Hospital Administration (1999).
  • Master in Business Administration and Health Management at IBMEC Business School-­‐ RJ, extended to Johns Hopkins Medicine, Baltimore, USA (2000).
  • Master in Business Administration and Marketing at Pontifícia Universidade Católica -­‐ RJ (2002).

Professional Work and Positions:

  • Researcher at National Institute of Science and Technology for Health Technology Assessment (IATS) CNPq/Brazil.
  • Researcher and director at Latin American Research Center of Biotechnology -­‐ CLAPBio
  • Director Vice President at the Brazilian Society of Biotechnology (SBBiotec)
  • Subsecretary for Biotechnology, Science and Health development at Federal District Government, Brasilia, Brazil (2012 – 2014)

Jim Greenwood, President & Chief Executive Officer, BIO

James C. Greenwood is President and CEO of the Biotechnology Innovation Organization (BIO) in Washington, D.C., which represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the annual BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. Since his appointment in January of 2005, he has markedly enhanced the trade association’s capacity – increasing both its staff and budget by nearly fifty percent. BIO is now a world class advocacy organization playing a leading role in shaping public policy on a variety of fronts critical to the success of the biotechnology industry at the state and national levels as well as internationally. Mr. Greenwood represented Pennsylvania's Eighth District in the U.S. House of Representatives from January 1993 through January 2005. A senior member of the Energy and Commerce Committee, he was widely viewed as a leader on health care and the environment. From 2001 to 2004, Mr. Greenwood served as Chairman of the Energy and Commerce Committee Subcommittee on Oversight and Investigation with oversight authority over issues in the full Committee's vast jurisdiction. He led hard-hitting investigations into corporate governance at Enron, Global Crossing and WorldCom; terrorist threats to our nation's infrastructure; and waste and fraud in federal government agencies. Prior to his election to Congress, Mr. Greenwood served six years in the Pennsylvania General Assembly (1981-86) and six years in the Pennsylvania Senate (1987-1992). Mr. Greenwood graduated from Dickinson College in 1973 with a BA in Sociology. From 1977 until 1980, he worked as a caseworker with abused and neglected children at the Bucks County Children and Youth Social Service Agency. Mr. Greenwood is married with three children and resides in Upper Makefield, Pennsylvania.

Laura Hammel, Intellectual Property Attaché for Mercosur, Guianas, and Suriname, U.S. Commercial Service

Laura Hammel is the intellectual property (IP) attaché based at the U.S. consulate in Rio de Janeiro, Brazil. She covers Argentina, Brazil, French Guiana, Guyana, Paraguay, Suriname, Uruguay, and Venezuela. Ms. Hammel’s responsibilities include representing U.S. intellectual property interests in her region through advocacy of high standards of intellectual property protection and enforcement, engaging with countries in her region to improve their intellectual property regimes, and serving as the U.S. Patent and Trademark Office’s representative on U.S. delegations to international meetings on intellectual property in the region. Prior to becoming an attaché, Ms. Hammel was an attorney-advisor in the USPTO’s Office of Policy and International Affairs from 2012–2016, where her work focused on international and domestic trademark law. She worked on matters in Latin America and the Caribbean, China, the Middle East and North Africa, Japan, the Association of Southeast Asian Nations, and the TM5. During her tenure at the USPTO, Ms. Hammel also held the position of acting senior attorney, where she supervised a law office of approximately 25 trademark examining attorneys. She also completed a work project in the copyright group in the Office of Policy and International Affairs, where her work focused on research in the field of resale royalties for visual artists, broadcasters’ rights, and miscellaneous copyright issues in the Middle East and North Africa. She began her tenure at the USPTO in 2005 as a trademark examining attorney. Ms. Hammel holds an LL.M. in intellectual property law from the George Washington University Law School and a J.D. from the University of Maryland School of Law. She completed her undergraduate degree at the University of Maryland, Baltimore County, where she studied 19th and 20th century art history and theory.

Thomas Mallet, Technology Development Manager, Axens

Thomas Mallet is the Technology Development Manager in the Technology Development & Innovation Division for Axens. Mallet joined Axens in 2005 as Technology Manager in biodiesel technologies. In 2008, he moved to the Olefins Technology Group and has been involved in various technologies aiming at upgrading the light olefins from steam cracking and FCC such as etherification, heterogeneous oligomerization and Atol (ethanol to ethylene). Since the end of 2014, he coordinates R&D activities related to Biofuels & Biobased Chemical Components. Mallet holds an Engineering degree in Chemistry from the Institut National des Sciences Appliquées de Rouen.

Matthew McBride, Manager, Science IP, Chemical Abstracts Service

Matthew McBride is the manager for Science IP®, the official research service of CAS, a division of the American Chemical Society, where he also conducts research on behalf of Science IP clients. Matt became a member of the team in 2010, after spending six years as a Senior Application Specialist providing STN and SciFinder technical training to CAS customers. He holds a Master of Science degree in plant pathology from the University of Minnesota and a Bachelor of Science degree in molecular biology from Purdue University. In addition to his research experience at CAS, Matt was an information consultant with Thomson Reuters and a biologist at Rohm and Hass.

John Melo, President & Chief Executive Officer, Amyris

Mr. Melo has 30 years of combined experience as an entrepreneur and thought leader in developing and growing technology companies and as a senior executive in the Oil & Gas industry. As President and Chief Executive Officer, Mr. Melo has led Amyris through successful technology development, industrial start up, product development and commercialization and a series of funding rounds, including the initial public offering. Before joining Amyris in 2007, Mr. Melo served in various senior executive positions at BP Plc (formerly British Petroleum) most recently as President of U.S. fuels operations where he successfully led a business transformation and significantly improved the financial performance. During his tenure at BP, Mr. Melo also served as Chief Information Officer of the refining and marketing segment; Senior Advisor for e-business strategy to Lord Browne, BP group chief executive; and Director of global brand development. In this last role, he helped develop the “Helios” re-branding effort. Before joining BP, Mr. Melo was with Ernst & Young. Mr. Melo currently serves on the board of directors of Renmatix Inc., serves on the board of directors of BayBio, serves on the Bio Industrial and Environmental section governing board, is a member of the Council for the Portuguese Diaspora and is a member of Young Presidents’ Organization (YPO). He was formerly an appointed member to the U.S. section of the U.S.-Brazil CEO Forum. When not working on the mission of making sustainable chemistry mainstream or championing the eradication of malaria, John enjoys skiing, reading and time with his family on the island of Pico in the Azores, his childhood home.

Rafael Henrique Rodrigues Moreira, Director, Department of Innovative Technologies, Ministry of Industry, Foreign Trade and Services (MDIC)

Rafael Moreira received a Bachelor's Degree in Economics from Federal University of Minas Gerais (UFMG) and earned a Master in Economics with an emphasis in Econometrics from University of São Paulo (USP) and a Master in Computer Sciences from University of Brasília (UNB). He is PhD candidate in Economics from University of Louvain and Paris I Sorbonne (European Doctorate). Government Manager, Mr. Moreira served as Economic Advisor in National Telecommunications Agency (ANATEL), Deputy Director in Ministry of Development and Trade (MDIC) and Deputy Secretary for ICT Policies in Ministry of Science, Technology and Innovation (MCTI). He has accumulated public policies positions in the research & development area within digital economy industry and science, technology and innovation ecosystem with emphasis in the startups segment. He is currently Deputy Secretary for Innovation and New Businesses in the Ministry of Industry, Trade and Services, where he is in charge of National Biotechnology Committee (CNB).

Gerard Ostheimer, Global Lead, Sustainable Bioenergy Group, UN Sustainable Energy For All (SE4ALL)

Dr. Ostheimer is the Global Lead for Sustainable Bioenergy under the UN and World Bank initiative Sustainable Energy For All (SE4All). He promotes the development of well-functioning public-private partnerships that work towards achieving SE4All’s goals of increasing energy access and increasing the use of renewable energy. Previously, Dr. Ostheimer served as a Science Advisor for the Foreign Agriculture Service of the U.S. Department of Agriculture where he worked at the interface between sustainability, biofuels, international development and international trade in agricultural products. Dr. Ostheimer represented the U.S. to the Global Bioenergy Partnership (GBEP). Dr. Ostheimer earned a Ph.D. in molecular biology at the University of Oregon and did postdoctoral work in the systems biology of cancer at MIT. While at MIT, Dr. Ostheimer co-founded the MIT Science Policy Initiative that educates young scientists about the role policy plays in promoting science and how science contributes to making good public policy.

João Paulo Pieroni, Head of Industry and Services Health Department, The Brazilian Development Bank (BNDES)

João Paulo Pieroni is Head of Industry and Services Health Department at the Brazilian Development Bank (BNDES), a key state owned long term financing institution focused on innovation and infrastructure. His team is Bank's responsible for investments projects analysis and public policies to Brazilian health sector. Mr. Pieroni graduated in economics and has a M.Sc. in Political Economy. He has published several papers on life sciences challenges and opportunities for Brazil. He’s participated in several industry and government foruns on innovation and health policy.

Luiz Otávio Pimentel, President, Brazilian Patent and Trademark Office (INPI)

Luiz Otávio Pimentel holds a Bachelor's degree in Legal and Social Sciences at the University of Law of Cruz Alta (1984), master's degree in Law from the Federal University of Santa Catarina (1993) and PhD in Legal Sciences at the National University of Asunción (1999). Dr. Pimentel is associate professor at the Federal University of Santa Catarina (UFSC) and Professor of the Academy of intellectual property, innovation and development of the Brazilian National Institute of Industrial Property (INPI). In addition, Mr. Pimentel is Ad Hoc arbitrator of the Arbitration Court of MERCOSUR. Dr. Pimentel has a very large practical experience in the field of Law and Public Policy, especially in Intellectual Property and Innovation, with extensive academic work related to. On July, 28th of 2015, Dr. Pimentel was designated President of INPI.

Marité Prieto, Regulatory Affairs Director, Amgen

Marité Prieto Faria is the regulatory affairs head of Amgen Brazil since April 2012. Prior to this position at Amgen Mrs. Prieto worked at Eli Lilly and Co. as Therapeutic Area Leader (August 2002 – January 2004, then as a Clinical Operations Manager (February 2004-March 2007) and at last as Regulatory Affairs Senior Manager (April 2007 – March 2012). Mrs. Prieto has a bachelor degree in Pharmacy (1999) from the Pharmacy and Biochemistry Faculty of the University of São Paulo (USP). She has post graduate degree in Business Management (2004) from the Economics and Business Faculty of University of São Paulo and she also has a MBA in Business Development (2005) from the same faculty. Mrs. Prieto has Portuguese as her mother language and she is fluent in English and Spanish as well.

Raquel Rinke, Laboratory Manager, Royal DSM 

Raquel Rinke received a Bachelor's Degree in Biological Sciences with an emphasis in Molecular, Cellular and Functional Biology from Federal University of Rio Grande do Sul (UFRGS) and earned a Master in Biotechnology from Federal University of São Carlos (UFSCar). She has accumulated research & development experience within the sugar & ethanol industry and biotechnological processes with a specialization in second generation ethanol application activities since 2009.

Currently, Raquel is leading research & development activities for Bio-based Products & Services (BP&S) for DSM Latin America, where the main focus is to provide technology and accelerate the local implementation of biofuels and biochemical products in Latin America. Raquel is also responsible for local regulatory affairs (CTNBio and CGEN) and the local focal point for intellectual property support for the DSM Biotechnology business in Brazil.

Roberta Roesler, PhD, Research & Development Manager, Natura

Roberta Roesler, PhD, is a Food Engineer with 16 years in the Food and Cosmetics Industry as a R&D Manager. Dr. Roesler’s has concentrated work experience as a group leader in Research and Development Areas, including Development Products of several Cosmetic Categories (Body Care, Baby Care, Male Care and Deodorants) and Development of Natural and Biotech Ingredients for Food and Cosmetics application. Nowadays, Dr. Roesler is Leader of the Natural Ingredients Research Group in Natura, which has the challenge of discovering and developing a variety of natural and sustainable ingredients from vegetable and microbial sources for application across Natura business interests. The group is composed by a large number of researches and scientists and also is responsible for process development from laboratory scale to full-scale manufacturing.

Daniel Sabara, Chief Executive Officer, Beraca

Daniel Sabará is the Chief Executive Officer of Beraca. Sabará graduated in Business Management, specialized in Marketing and Branding and post graduated in Capital Market. He has extensive experience in sustainability strategic planning and management, focused on designing and developing business oriented models to serve the international market, mainly based on Brazilian biodiversity products and supply chains. As an active speaker on sustainable development and ethical sourcing round tables and events, Sabará has supported Beraca on successfully becoming an awarded benchmark of sustainable development modern business. He has addressed, along with other key decision makers, the discussions involving the new legislation related to access and benefit sharing practices through the sustainable use of the Brazilian biodiversity. Sabará has successfully implemented many initiatives concerning the connection between cosmetic product manufactures and traceable local community supply chains, through new and innovative raw materials, mostly developed using green chemistry methodologies and partners. He has incorporated non-timber products into forest management projects from private lands and public forest concessions, allowing the creation of a virtuous cycle between sustainable extraction practices and socio-economic effectiveness. Sabará has also identified marketing and innovation trends and opportunities for the beauty market and conducted projects that culminated in added value to international products and brands, biodiversity preservation and additional income to local communities.

Bernardo Silva, Executive President, Brazilian Industrial Biotechnology Association (ABBI), (Brazil)

Bernardo Silva was appointed Executive President of the Brazilian Industrial Biotechnology Association (ABBI) in January 2015. Prior to joining ABBI, Bernardo worked at the World Economic Forum headquarters in Cologny, Switzerland, overseeing corporate and membership affairs in South America. He also served in a variety of government affairs and policy advocacy roles within the Brazilian Trade and Investment Promotion Agency (ApexBrasil), and with the United States Department of Agriculture (USDA) in Brasilia, Brazil.

Bernardo earned his MA degree from Tufts Universityís Fletcher School of Law and Diplomacy, MBA from FundaÁ„o Get˙lio Vargas (FGV), and holds a BS degree in Economics from UniCEUB. Bernardo was also the first Brazilian to ever be accepted as a Global Leadership Fellow at the World Economic Forum.

Luciano Cunha de Sousa, New Business Coordinator, Secretariat of Innovation, Ministry of Industry, Foreign Trade and Services (MDIC)

Luciano Cunha de Sousa holds a degree in Electric Engineering, a masters in Economics, and a PHD in Public Management, with researches in innovation public policies in biotechnology sector. Nowadays he is coordinating the biotechnology and IT innovation sector at the Ministry of Industry, Foreign Trade and Services. He is also a professor at a faculty in Brasília.

Marcos Vinicius de Souza, Secretary of Innovation, Ministry of Industry, Foreign Trade and Services (MDIC)

Secretary of Innovation at the Ministry of Development, Industry and Foreign Trade (MDIC) and civil servant in the Foreign Trade Analyst career. Has a Bachelor of Business Administration Degree from EAESP‐FGV (São Paulo Business Administration School of the Getúlio Vargas Foundation), an MBA in Cluster Development from ECLAC/ONU and training in innovation policy by VINNOVA – the Swedish Innovation Agency. At MDIC, worked in the Foreign Trade Chamber - CAMEX and was Coordinator of the Franchises Forum in the Secretariat of Production Development. Member of the main Consulting Councils and Steering Committees related to innovation policy in the Brazilian Federal Government. Before joining the Ministry, worked in strategy consulting and in investment funds specialized in venture capital for high tech businesses.

Antonio Alberto Stuchi, Executive Director, Technologies and Projects, Raízen

Antonio Alberto Stuchi is Executive director of Technologies and Projects at Raízen. Mr. Stuchi has a degree in chemical engineering by Universidade Estadual de Campinas and a business management MBA by Fundação Getúlio Vargas (FGV). Mr. Stuchi has more than 30 years’ experience in sugar and alcohol industry. He has occupied several positions, performing at agribusiness production and management, bioenergy, inovation and techonologies as manager and director at Guarani S/A. In 2008 he started working as Industial Director at Cosan. After the JV, he became Agro-Industrial Production Director at Raízen. In 2015, as Executive Director of Technologies and Projects, he led the second-generation ethanol´s project.

Thiago Terada, Head of Sustainability and Corporate Affairs, Beraca

Thiago Terada graduated in International Affairs with an MBA in sustainability at Università Cattolica del Sacro Cuore, Italy. His career has focused on Sustainability, Government Relations and Corporate Affairs in different segments, mainly in the chemical sector. Currently he is working for Beraca as Head of Sustainability and Corporate Affairs, responsible for the activities in the field, respecting the people who live there and empowering families toward more sustainable activities. In 2014, Thiago was part of the Brazilian delegation at the COP12 in South Korea and he has made several presentations regarding ABS, Nagoya Protocol and Brazilian legislation in various countries.

Priscila Torres, President, BIORED Brasil

EncontrAR Group’s President, Grupar-RP’s vice president, social entrepreneur at Blogueiros da Saúde and blogger at Blog Artrite Reumatoide. Priscila spurred the creation of “Biored Brasil”, which brings 28 patient organizations together in order to stand for the advocacy practice and the impact on public policies about biopharmaceuticals and biosimilars in Brazil. Authoress of #TwittAR campaign that was a social mobilization on social media to update about Clinical Protocol and Therapeutic Guidelines of Rheumatoid Arthritis at the Ministry of Health. Creator of “Blogueiros da Saúde” that is a social project of empowerment and education for health bloggers and digital activists. Works as coordinator, editor and writer on the following institutional blogs: Grupar-RP, EncontrAR and Biored Brasil, Blogueiros da Saúde and Blog Artrite Reumatoide – an authorial communication channel about rheumatic diseases. Technique in Nursing, specialized in Hospital Quality Management. Incomplete under graduation in Nursing and graduation student of the Social Communication course focused in Journalism, at Faculdades Metropolitanas Unidas.


*As of 10/18/2016